Apellis Pharmaceuticals (APLS) Interest Coverage Ratio (2020 - 2025)
Historic Interest Coverage Ratio for Apellis Pharmaceuticals (APLS) over the last 6 years, with Q3 2025 value amounting to 19.79.
- Apellis Pharmaceuticals' Interest Coverage Ratio rose 62448.54% to 19.79 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.79, marking a year-over-year increase of 12900.11%. This contributed to the annual value of 4.08 for FY2024, which is 7663.51% up from last year.
- Latest data reveals that Apellis Pharmaceuticals reported Interest Coverage Ratio of 19.79 as of Q3 2025, which was up 62448.54% from 2.98 recorded in Q2 2025.
- Over the past 5 years, Apellis Pharmaceuticals' Interest Coverage Ratio peaked at 19.79 during Q3 2025, and registered a low of 56.09 during Q3 2021.
- In the last 5 years, Apellis Pharmaceuticals' Interest Coverage Ratio had a median value of 16.41 in 2023 and averaged 16.79.
- Per our database at Business Quant, Apellis Pharmaceuticals' Interest Coverage Ratio crashed by 31878.48% in 2021 and then soared by 62448.54% in 2025.
- Quarter analysis of 5 years shows Apellis Pharmaceuticals' Interest Coverage Ratio stood at 29.62 in 2021, then increased by 28.43% to 21.2 in 2022, then soared by 46.14% to 11.42 in 2023, then skyrocketed by 80.13% to 2.27 in 2024, then skyrocketed by 972.3% to 19.79 in 2025.
- Its Interest Coverage Ratio stands at 19.79 for Q3 2025, versus 2.98 for Q2 2025 and 7.54 for Q1 2025.